产品名称
Aurora™-PLC, Avanti Research™ - A Croda Brand 550002P, powder
assay
>95% (TLC)
form
powder
packaging
pkg of 1 × 10 mg (with screw cap (550002P-10mg)), pkg of 1 × 100 mg (with screw cap (550002P-100mg))
manufacturer/tradename
Avanti Research™ - A Croda Brand 550002P
shipped in
dry ice
storage temp.
−20°C
General description
Aurora™ nanoparticles from Avanti are useful in high resolution liposome imaging studies. It also enables identification and quantification of lipid species. Aurora™-PLC gold nanoparticle is stabilized with dodecanethiol, coated with 1-myristoyl-sn-glycero-3-phosphocholine.
3-5nm gold nanoparticle stabilized with dodecanethiol, coated with 1-myristoyl-sn-glycero-3-phosphocholine
Packaging
5 mL PTFE Vial with Screw Cap (550002P-100mg)
5 mL PTFE Vial with Screw Cap (550002P-10mg)
Legal Information
Aurora is a trademark of Avanti Polar Lipids, LLC
Avanti Research is a trademark of Avanti Polar Lipids, LLC
signalword
Danger
hcodes
Hazard Classifications
Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1C - Skin Sens. 1
存储类别
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Iris E Allijn et al.
ACS nano, 7(11), 9761-9770 (2013-10-17)
Low-density lipoprotein (LDL) plays a critical role in cholesterol transport and is closely linked to the progression of several diseases. This motivates the development of methods to study LDL behavior from the microscopic to whole-body level. We have developed an
Avanti lipid tools: connecting lipids, technology, and cell biology
Sims KH, et al.
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1841(8), 1038-1048 (2014)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 550002P-10MG | 04061835184743 |
| 550002P-100MG | 04061835184736 |